Cite
HARVARD Citation
Meyer, J. et al. (2018). A Phase I Clinical Trial of the Phosphatidylserine-targeting Antibody Bavituximab in Combination With Radiation Therapy and Capecitabine in the Preoperative Treatment of Rectal Adenocarcinoma. American journal of clinical oncology. p. . [Online].